Latest Period
Q1 2026
Security Snapshot
TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share (TEVA) Institutional Ownership
CUSIP: 881624209
13F Institutional Holders and Ownership History from Q1 2014 to Q1 2026
Institutions Reporting
643
Shares (Excl. Options)
672,262,275
Price
$30.12
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Ordinary Shares, par value NIS 0.01 per share
- Symbol
- TEVA on NYSE
- Shares outstanding
- 1,148,777,709
- Reported price per share
- $35.81
- Price from insider filings
- $35.81
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 672,262,275
- Total reported value
- $20,140,096,765
- Portfolio coverage rank
- 0.02%
- Share change
- -16,344,243
- Value change
- -$614,560,826
- Number of holders
- 643
Security identity
Issuer context
Latest holder snapshot
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Key facts
- TEVA - TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share is tracked under CUSIP 881624209.
- 643 institutions reported positions in Q1 2026.
- 3 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 627 to 643 between Q4 2025 and Q1 2026.
- Reported value moved from $21,442,592,689 to $20,140,096,765.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 643 institutions filings for Q1 2026.
Security key
881624209
Latest holder period
Q1 2026
13F holders
643
13D/G owners
3
CIK / CUSIP context first
Open Q1 2026 holders
TEVA full holder history
TEVA PHARMACEUTICAL INDUSTRIES LTD SEC filings
TEVA PHARMACEUTICAL INDUSTRIES LTD company facts
TEVA PHARMACEUTICAL INDUSTRIES LTD insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 881624209:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
3
Security
TEVA
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Migdal Insurance & Financial Holdings Ltd. | 5.4% | $2,022,794,213 | 61,689,363 | Migdal Insurance & Financial Holdings Ltd | 31 Dec 2025 | |||
| MENORA MIVTACHIM HOLDINGS LTD. | 5% | $961,943,099 | 57,395,173 | Menora Mivtachim Holdings Ltd | 16 Jul 2025 | |||
| Phoenix Financial Ltd. | 5% | $961,741,722 | 57,383,158 | Phoenix Financial Ltd. | 14 Jul 2025 |
As of 31 Mar 2026, 643 institutional investors reported holding 672,262,275 shares of TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share (TEVA). This represents 59% of the company’s total 1,148,777,709 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
44%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BlackRock, Inc. | 5.7% | 65,136,464 | +12% | 0.03% | $1,961,910,299 |
| Harel Insurance Investments & Financial Services Ltd. | 4% | 45,956,714 | +2.2% | 9.4% | $1,384,216,000 |
| Phoenix Financial Ltd. | 3.7% | 42,777,414 | +4.1% | 12% | $1,288,455,710 |
| WCM INVESTMENT MANAGEMENT, LLC | 3.6% | 40,820,600 | +191% | 2.6% | $1,157,264,010 |
| MENORA MIVTACHIM HOLDINGS LTD. | 3.4% | 39,626,383 | +0.79% | 5.7% | $1,193,546,656 |
| Clal Insurance Enterprises Holdings Ltd | 3.3% | 38,446,506 | +2.8% | 6.9% | $1,148,252,000 |
| Migdal Insurance & Financial Holdings Ltd. | 3.3% | 37,902,212 | +1.3% | 9.9% | $1,141,614,625 |
| FMR LLC | 2.9% | 33,132,795 | +14% | 0.05% | $997,959,810 |
| Lingotto Investment Management LLP | 2.4% | 27,770,857 | -2.3% | 17% | $836,458,213 |
| STATE STREET CORP | 1.5% | 17,790,020 | +2.5% | 0.02% | $535,835,402 |
| Rubric Capital Management LP | 1.3% | 15,250,000 | -29% | 5.6% | $459,330,000 |
| Altshuler Shaham Ltd | 1% | 11,463,621 | +35% | 6.1% | $334,636,318 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.92% | 10,564,988 | +2.3% | 0.02% | $316,254,244 |
| Capital World Investors | 0.77% | 8,833,566 | +274% | 0.04% | $266,066,970 |
| NORTHERN TRUST CORP | 0.66% | 7,635,688 | +36% | 0.03% | $229,986,922 |
| MORGAN STANLEY | 0.65% | 7,426,253 | -12% | 0.01% | $223,678,831 |
| WELLINGTON MANAGEMENT GROUP LLP | 0.63% | 7,251,828 | +6.9% | 0.04% | $218,425,059 |
| JPMORGAN CHASE & CO | 0.59% | 6,762,744 | +466% | 0.01% | $191,723,834 |
| GLENVIEW CAPITAL MANAGEMENT, LLC | 0.58% | 6,660,220 | -60% | 5.4% | $200,605,826 |
| Alyeska Investment Group, L.P. | 0.48% | 5,519,030 | +56% | 0.47% | $166,233,184 |
| Polar Capital Holdings Plc | 0.45% | 5,175,058 | +3.8% | 0.68% | $155,872,747 |
| GOLDMAN SACHS GROUP INC | 0.42% | 4,826,245 | -18% | 0.02% | $145,366,499 |
| JANUS HENDERSON GROUP PLC | 0.42% | 4,816,657 | +1.5% | 0.07% | $145,076,310 |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 0.38% | 4,376,270 | -41% | 0.11% | $131,813,252 |
| BESSEMER GROUP INC | 0.38% | 4,350,483 | +1.6% | 0.21% | $131,036,000 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
49
Latest
Q1 2026
Rows shown
1-25 of 49
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 672,262,275 | $20,140,096,765 | -$614,560,826 | $30.12 | 643 |
| 2025 Q4 | 686,977,826 | $21,442,592,689 | +$1,230,700,950 | $31.21 | 627 |
| 2025 Q3 | 657,155,100 | $13,261,324,401 | -$1,074,548,979 | $20.20 | 544 |
| 2025 Q2 | 712,590,449 | $11,941,932,547 | +$36,824,124 | $16.76 | 533 |
| 2025 Q1 | 711,693,842 | $10,931,543,829 | +$519,379,518 | $15.37 | 553 |
| 2024 Q4 | 665,647,648 | $14,670,317,479 | +$818,691,314 | $22.04 | 576 |
| 2024 Q3 | 620,854,841 | $11,183,045,547 | +$327,878,111 | $18.02 | 537 |
| 2024 Q2 | 607,728,519 | $9,874,096,775 | +$630,049,704 | $16.25 | 528 |
| 2024 Q1 | 570,414,049 | $8,044,022,392 | -$52,732,472 | $14.11 | 474 |
| 2023 Q4 | 577,047,792 | $6,069,688,726 | +$223,053,462 | $10.44 | 442 |
| 2023 Q3 | 554,042,366 | $5,650,669,709 | +$626,794,069 | $10.20 | 427 |
| 2023 Q2 | 494,500,315 | $3,725,733,619 | -$615,772,920 | $7.53 | 415 |
| 2023 Q1 | 558,872,500 | $4,939,868,087 | -$36,845,034 | $8.85 | 431 |
| 2022 Q4 | 546,063,896 | $4,978,922,006 | -$17,646,117 | $9.12 | 412 |
| 2022 Q3 | 560,076,320 | $4,512,924,774 | +$430,391,292 | $8.07 | 395 |
| 2022 Q2 | 505,606,590 | $3,800,507,049 | -$46,832,800 | $7.52 | 423 |
| 2022 Q1 | 514,571,916 | $4,831,771,215 | +$15,212,208 | $9.39 | 420 |
| 2021 Q4 | 505,268,193 | $4,044,921,275 | -$275,589,149 | $8.01 | 404 |
| 2021 Q3 | 527,166,334 | $5,134,182,484 | -$316,368,771 | $9.74 | 408 |
| 2021 Q2 | 560,418,706 | $5,548,640,366 | -$132,495,361 | $9.90 | 423 |
| 2021 Q1 | 572,281,687 | $6,602,414,033 | +$11,656,292 | $11.54 | 432 |
| 2020 Q4 | 569,047,097 | $5,481,032,100 | +$43,379,354 | $9.65 | 425 |
| 2020 Q3 | 567,029,372 | $5,101,188,907 | -$198,579,913 | $9.01 | 421 |
| 2020 Q2 | 578,768,724 | $7,127,077,578 | +$321,923,360 | $12.33 | 435 |
| 2020 Q1 | 553,974,646 | $4,971,872,721 | -$440,161,645 | $8.98 | 430 |